Biological response modifiers: Preclinical evaluation and clinical activity
- 31 December 1984
- journal article
- clinical trial
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 1 (3) , 259-294
- https://doi.org/10.1016/s1040-8428(84)80014-1
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- Immunoregulation of Malignant LymphomaNew England Journal of Medicine, 1982
- Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype AntibodyNew England Journal of Medicine, 1982
- Effects of HuIFN-α2 and HuIFN-α (Namalwa) on Breast Cancer Cells Grown in Culture and as Xenografts in the Nude MouseJournal of Interferon Research, 1982
- Regulation of the Immune Response by Idiotypic-Antiidiotypic InteractionsNew England Journal of Medicine, 1981
- Regulation of the Immune Response — Inducer and Suppressor T-Lymphocyte Subsets in Human BeingsNew England Journal of Medicine, 1980
- The comparative effects of isoprinosine, levamisole, muramyl dipeptide and SM1213 on lymphocyte and macrophage proliferation and activation in vitroInternational Journal of Immunopharmacology, 1979
- The Suppressor-Cell Network in CancerNew England Journal of Medicine, 1978
- The Suppressor-Cell Network in CancerNew England Journal of Medicine, 1978
- Antisera to acute lymphoblastic leukemia cellsClinical Immunology and Immunopathology, 1975
- Antibody to a molecularly-defined antigen confined to a tumour cell surfaceNature, 1975